drugset / Trial / NCT00005786
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have relapsed or refractory lymphoma or leukemia. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
Timeline
- Start
- 2001-01
- Primary completion
- 2004-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | arsenic trioxide | Small molecule | — | Intravenous |